Executives On The Move: Celgene Founder Adds Cerecor To His Chair Portfolio
• By Regina Paleski
Sol Barer, founder and former CEO of Celgene, has been appointed chair of Cerecor; he is already chair of Teva, Centrexion Therapeutics and NexImmune. Also, PTC Therapeutics announces promotions and ProBioGen gets a new CEO.
Joshi joins the parent company of Citeline, which houses flagship publications Scrip and Pink Sheet, to focus on AI, business harmonization and long-term growth.
Recent moves in the industry include C-suite changes at Abvance Therapeutics, plus Galapagos gets new chief financial officer from Horizon Therapeutics.